Understanding the cell wall of Streptococcus pyogenes and its role in infections
Biogenesis and Function of Streptococcus Pyogenes Cell Wall
This study is looking at how a specific part of the Group A streptococcus bacteria, which can cause serious infections, is made and changed, with the hope of finding new ways to create a vaccine to help protect people from these tough-to-treat infections.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kentucky NIH-funded |
| Lab location | 1 site (Lexington, United States) |
| Project ID | NIH-10728339 on NIH RePORTER |
What this research studies
This research investigates the cell wall of Group A streptococcus (GAS), a significant bacterial pathogen responsible for severe infections like necrotizing fasciitis and cellulitis. The study focuses on the biogenesis and modifications of the Group A Carbohydrate (GAC), which is crucial for the bacteria's survival and resistance to antibiotics. By employing genetic, biochemical, and structural methods, the research aims to uncover how these modifications contribute to the bacteria's ability to cause disease and resist treatment. The ultimate goal is to inform the development of a vaccine against GAS infections, which are currently difficult to treat.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of severe Group A streptococcus infections, such as those with compromised immune systems or chronic skin conditions.
Not a fit: Patients with non-invasive GAS infections or those who do not have any risk factors for severe infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of an effective vaccine against severe GAS infections, significantly improving patient outcomes.
How similar studies have performed: Other research has shown promise in targeting bacterial cell wall components for vaccine development, indicating that this approach has potential for success.
Where this research is happening
Lexington, United States
- University of Kentucky — Lexington, United States (Active)
Researchers
- Principal investigator: Korotkova, Natalia — University of Kentucky
- Study coordinator: Korotkova, Natalia
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.